Explosive growth predicted in need for diabetes care products:
This article was originally published in Clinica
Executive Summary
Some 330 million people globally will be suffering from diabetes in 20 years' time. That is the stark prediction that was made on World Diabetes Day on November 12, as reported by Health First Europe. In the EU, the European Commission estimates that 19 million people, or 4% of the population are current affected by diabetes, and that this number is likely to increase to 26 million by 2030, or 6% of the population. In the EU, type-2 diabetes, which is often associated with obesity, costs some E15bn ($11.6bn) a year. The World Health Organisation estimates that the number of deaths attributed annually to diabetes is about 3.2 million, yet at least 50% of all people with diabetes are not aware of their life-threatening condition.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.